Recombinant Mouse Fas/TNFRSF6/CD95 Protein, Active
Beta LifeScience
SKU/CAT #: BLK-02192P-100UG
Mouse Fas on Tris-Bis PAGE under reduced condition. The purity is greater than 95%.
Recombinant Mouse Fas/TNFRSF6/CD95 Protein, Active
Beta LifeScience
SKU/CAT #: BLK-02192P-100UG
Collections: Recombinant proteins
Our products are highly customizable to meet your specific needs. You can choose options such as endotoxin removal, liquid or lyophilized forms, preferred tags, and the desired functional sequence range for proteins. Submitting a written inquiry expedites the quoting process.
Product Overview
Description | Recombinant Mouse Fas/TNFRSF6/CD95 Protein is expressed from HEK293 with hFc tag at the C-Terminus.It contains Gln22-Arg169. |
Purity | > 95% as determined by Tris-Bis PAGE;> 95% as determined by HPLC |
Accession | P25446 |
Target Symbol | Fas/TNFRSF6/CD95 |
Synonyms | FASLG receptor; CD95; APT1; FAS1; TNFRSF6; FAS; ALPS1A; APO1; FASTM; FasR |
Species | Mouse |
Expression System | HEK293 |
Tag | C-hFc |
Expression Range | Gln22-Arg169 |
Mol. Weight | The protein has a predicted MW of 43.3 kDa. Due to glycosylation, the protein migrates to 60-65 kDa based on Tris-Bis PAGE result. |
Form | Lyophilized |
Formulation | Lyophilized from 0.22um filtered solution in PBS (pH 7.4). Normally 8% trehalose is added as protectant before lyophilization. |
Endotoxin | Less than 1EU per ug by the LAL method. |
Activity | Immobilized Human Fas Ligand, His Tag at 1ug/ml (100ul/well) on the plate. Dose response curve for Mouse Fas, hFc Tag with the EC50 of 0.25ug/ml determined by ELISA. Contact us for detailed testing images. |
Storage | Reconstituted protein stable at -80°C for 12 months, 4°C for 1 week. Use a manual defrost freezer and avoid repeated freeze-thaw cycles. |
Shipping | Shipped at ambient temperature. |
Gene Background | CD95 (also known as Fas) is a member of the tumor necrosis factor receptor (TNFR) superfamily. Its cognate ligand, CD95L, is implicated in immune homeostasis and immune surveillance. Mutations in this receptor are associated with a loss of apoptotic signaling and have been detected in an autoimmune disorder called autoimmune lymphoproliferative syndrome (ALPS) type Ia, which shares some clinical features with systemic lupus erythematosus (SLE). |